Skip to Content
Merck
CN
  • Simplification of childhood hypertension definition using blood pressure to height ratio among US youths aged 8-17years, NHANES 1999-2012.

Simplification of childhood hypertension definition using blood pressure to height ratio among US youths aged 8-17years, NHANES 1999-2012.

International journal of cardiology (2014-12-03)
Bo Xi, Meixian Zhang, Tao Zhang, Shuangshuang Li, Lyn M Steffen
ABSTRACT

The fourth report on the diagnosis, evaluation, and treatment of high blood pressure (BP) established high BP diagnostic criteria using age-, sex-, and height-specific BP percentiles. However, these BP criteria are quite difficult for use by professionals in the clinic or children and their parents. We aimed to simplify the hypertension diagnostic criteria using BP to height ratio (BP/height) in US children and adolescents aged 8-17years. Data were obtained from a national representative sample of 14,624 US children and adolescents aged 8-17years enrolled in the continuous National Health and Nutrition Examination Survey 1999-2012. SBP to height ratio (SBPHR) was calculated as SBP (mmHg)/height (cm) and DBP to height ratio (DBPHR) was calculated as DBP (mmHg)/height (cm). The BP diagnostic criteria recommended by the fourth report were used as the "gold standard". Receive operator characteristic curve analysis was used to choose the optimal thresholds of SBPHR and DBPHR. The optimal thresholds for identifying pre-hypertension and hypertension among children aged 8-12years and adolescents aged 13-17years were determined. The negative predictive value (NPV) for identifying hypertension was nearly 100% for both children and adolescents, although the positive predictive value (PPV) ranged from 19% to 35%. The NPV for identifying pre-hypertension ranged from 95% to 99% for children and adolescents, and the PPV ranged from 11% to 52%. The optimal thresholds of SBPHR and DBPHR are simple and accurate for screening elevated BP, although PPV is relatively low because of the low prevalence of childhood hypertension.

MATERIALS
Product Number
Brand
Product Description

Supelco
Dibutyl phthalate, PESTANAL®, analytical standard
Supelco
Dibutyl phthalate, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Dibutyl phthalate, 99%
Dibutyl phthalate, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Sodium phosphate dibasic dodecahydrate, tested according to Ph. Eur.
Sigma-Aldrich
Sodium phosphate dibasic dodecahydrate, BioXtra, ≥99.0% (T)
Sigma-Aldrich
Sodium phosphate dibasic dodecahydrate, meets analytical specification of Ph. Eur., BP, E339, 98.5-102.5% (T)
Sigma-Aldrich
Sodium phosphate dibasic dodecahydrate, Vetec, reagent grade, 99%
Sigma-Aldrich
Sodium phosphate dibasic dodecahydrate, puriss. p.a., crystallized, ≥99.0% (T)